Cas no 147732-56-7 (Palmitoyl Tripeptide-1)
Palmitoyl Tripeptide-1 Chemical and Physical Properties
Names and Identifiers
-
- L-Lysine,N-(1-oxohexadecyl)glycyl-L-histidyl-
- N2-[(N-Palmitoylglycyl)-L-histidyl]-L-lysine
- Pal-GHK(PalMitoyl Tripeptide-1)
- N-(1-Oxohexadecyl)glycyl-N2-[N-[N-(1-oxohexadecyl)glycyl]-L-histidyl]-L-lysine
- PalMitoyl Tripeptide-1、3
- Pal-GHK
- PALMITOYL TRIPEPTIDE-1
- Palmitoyl oligopeptide
- N2-[N-[N-(1-oxohexadecyl)glycyl]-L-histidyl]-L-lysine
- Pal-AHK
- PAL-GLY-HIS-LYS-OH
- Palmiltoyl Tripeptide-1 (Pal-GHK)
- Palmitoyl Tripeptide-1, Bio-bustyl
- N-(1-Oxohexadecyl)glycyl-L-histidyl-L-lysine
- Pal-Gly-His-Lys
- Palmitoyl Tripeptide-1/Matrixyl 3000 / Pal-GHK
- Pal-GHK, >=95%
- Pal-GHK | Pal-Gly-His-Lys
- Palmitoyl Tripeptide-1/Pal-GHK
- Palmitoyl Tripeptide-1 /Palmitoyl oligopeptide
- Pal-Tripeptide-1
- AKOS028109254
- HY-P0047
- L-Lysine, N-(1-oxohexadecyl)glycyl-L-histidyl-
- 147732-56-7
- DTXSID90163794
- RV743D216M
- SCHEMBL322731
- CS-0005657
- (S)-2-((S)-3-(1H-Imidazol-5-yl)-2-(2-palmitamidoacetamido)propanamido)-6-aminohexanoic acid
- BYUQATUKPXLFLZ-UIOOFZCWSA-N
- C16-GHK
- (2S)-6-amino-2-[[(2S)-2-[[2-(hexadecanoylamino)acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid
- UNII-RV743D216M
- Q27288301
- AKOS030529561
- SCHEMBL26006164
- DB11297
- DA-76573
- Pal-val-gly-val-ala-pro-gly-oh
- palmitoyl-glycyl-histidyl-lysine
- Palmitoyl Tripeptide-1
-
- MDL: MFCD18251733
- Inchi: 1S/C30H54N6O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-27(37)33-22-28(38)35-26(20-24-21-32-23-34-24)29(39)36-25(30(40)41)17-15-16-19-31/h21,23,25-26H,2-20,22,31H2,1H3,(H,32,34)(H,33,37)(H,35,38)(H,36,39)(H,40,41)/t25-,26-/m0/s1
- InChI Key: BYUQATUKPXLFLZ-UIOOFZCWSA-N
- SMILES: O=C(CCCCCCCCCCCCCCC)NCC(N[C@H](C(N[C@H](C(=O)O)CCCCN)=O)CC1=CN=CN1)=O
Computed Properties
- Exact Mass: 578.41592
- Monoisotopic Mass: 578.41556884g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 6
- Hydrogen Bond Acceptor Count: 11
- Heavy Atom Count: 41
- Rotatable Bond Count: 29
- Complexity: 738
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.2
- Topological Polar Surface Area: 179?2
Experimental Properties
- Density: 1.105
- PSA: 179.3
Palmitoyl Tripeptide-1 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | P923900-1g |
Palmitoyl Tripeptide-1 |
147732-56-7 | 95% | 1g |
¥1,440.00 | 2022-01-14 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci16122-1g |
PalMitoyl Tripeptide-1 |
147732-56-7 | 98% | 1g |
¥1964.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci16122-5g |
PalMitoyl Tripeptide-1 |
147732-56-7 | 98% | 5g |
¥7552.00 | 2023-09-09 | |
| TRC | P161025-100mg |
Palmitoyl Tripeptide-1 |
147732-56-7 | 100mg |
$64.00 | 2023-05-17 | ||
| TRC | P161025-250mg |
Palmitoyl Tripeptide-1 |
147732-56-7 | 250mg |
$133.00 | 2023-05-17 | ||
| TRC | P161025-500mg |
Palmitoyl Tripeptide-1 |
147732-56-7 | 500mg |
$236.00 | 2023-05-17 | ||
| TRC | P161025-1g |
Palmitoyl Tripeptide-1 |
147732-56-7 | 1g |
$ 340.00 | 2022-06-03 | ||
| TargetMol Chemicals | TP2186-1g |
PalMitoyl Tripeptide-1 |
147732-56-7 | 1g |
¥ 6720 | 2024-07-19 | ||
| eNovation Chemicals LLC | D779664-1g |
N2-[N-[N-(1-Oxohexadecyl)glycyl]-L-histidyl]-L-lysine |
147732-56-7 | 95% | 1g |
$270 | 2023-09-03 | |
| TRC | P161025-1000mg |
Palmitoyl Tripeptide-1 |
147732-56-7 | 1g |
$414.00 | 2023-05-17 |
Palmitoyl Tripeptide-1 Suppliers
Palmitoyl Tripeptide-1 Related Literature
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
-
Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
Additional information on Palmitoyl Tripeptide-1
Palmitoyl Tripeptide-1: A Comprehensive Overview of its Biochemical Significance and Recent Applications
Palmitoyl Tripeptide-1, a synthetic peptide with the CAS number 147732-56-7, has emerged as a compound of significant interest in the field of biochemical research and pharmaceutical development. This tripeptide, composed of a sequence of amino acids linked by peptide bonds, is particularly noted for its potential role in skin health and anti-aging applications. The structural integrity and biological activity of Palmitoyl Tripeptide-1 are largely attributed to its unique arrangement of amino acids, which facilitates its interaction with various cellular receptors and signaling pathways.
The primary function of Palmitoyl Tripeptide-1 is centered around its ability to stimulate collagen production, a critical component of skin structure that maintains elasticity and firmness. Recent studies have highlighted its efficacy in promoting fibroblast activity, the cells responsible for producing collagen and elastin. This mechanism is particularly relevant in the context of anti-aging treatments, where maintaining skin integrity is paramount. The peptide's ability to enhance collagen synthesis not only improves skin texture but also aids in wound healing and tissue repair.
One of the most compelling aspects of Palmitoyl Tripeptide-1 is its bioavailability. Unlike many other skincare ingredients that may require complex delivery systems to penetrate the skin barrier, Palmitoyl Tripeptide-1 has demonstrated a high degree of permeability. This characteristic is attributed to its molecular size and the presence of palmitic acid residues, which facilitate its absorption into deeper layers of the skin. Such bioavailability ensures that the peptide can exert its biological effects more effectively, leading to noticeable improvements in skin health.
Recent advancements in cosmetic science have further elucidated the multifaceted benefits of Palmitoyl Tripeptide-1. Research indicates that it can also modulate other key skin components, such as hyaluronic acid and glycosaminoglycans, which are essential for maintaining hydration and moisture retention. This comprehensive approach to skin care makes Palmitoyl Tripeptide-1 a versatile ingredient suitable for a wide range of cosmetic formulations.
The therapeutic potential of Palmitoyl Tripeptide-1 extends beyond anti-aging applications. Studies have shown that it may play a role in protecting against oxidative stress, a common factor in various dermatological conditions. By enhancing the skin's natural antioxidant defenses, Palmitoyl Tripeptide-1 could help mitigate damage caused by environmental pollutants and UV radiation. This protective function underscores its value as an ingredient in formulations aimed at maintaining overall skin health.
In clinical settings, Palmitoyl Tripeptide-1 has been incorporated into topical treatments designed to address specific skin concerns. For instance, it has been used in combination with other peptides to enhance wound healing in patients with chronic wounds. The synergistic effects of these peptides can accelerate tissue regeneration while minimizing inflammation and scarring. Such applications highlight the compound's therapeutic versatility and its potential impact on patient outcomes.
The safety profile of Palmitoyl Tripeptide-1 is another area where it has garnered attention. Extensive toxicological studies have demonstrated that it is well-tolerated by human skin at typical concentrations used in cosmetic products. Unlike some synthetic compounds that may cause irritation or allergic reactions, Palmitoyl Tripeptide-1 exhibits low toxicity and minimal side effects. This safety makes it an attractive option for formulating skincare products intended for broad consumer use.
As research continues to uncover new insights into the mechanisms of action of Palmitoyl Tripeptide-1, its applications are likely to expand further. Emerging evidence suggests that it may also influence other cellular processes, such as cell differentiation and migration, which are crucial for maintaining healthy tissue function. These findings open up possibilities for using Palmitoyl Tripeptide-1 in treating a variety of conditions beyond mere aesthetic improvements.
The integration of Palmitoyl Tripeptide-1 into modern skincare regimens reflects a broader trend toward evidence-based cosmetic ingredients. By leveraging cutting-edge biochemical research, manufacturers can develop products that deliver tangible benefits backed by scientific validation. The case of Palmitoyl Tripeptide-1 exemplifies how innovative compounds can revolutionize anti-aging and therapeutic skincare solutions.
147732-56-7 (Palmitoyl Tripeptide-1) Related Products
- 137235-80-4(Fibrinogen-Binding Peptide)
- 126828-32-8(L-Alanyl-L-histidyl-L-lysine)
- 10101-30-1(2-acetamido-3-(1H-imidazol-4-yl)propanoic acid)
- 2497-02-1(N-Acetyl-L-histidine)
- 49557-75-7(Glycyl-l-histidyl-l-lysine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)